![Hong Ki Chae](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hong Ki Chae
Direttore/Membro del Consiglio presso Da Information Co., Ltd.
Patrimonio netto: 898 830 $ in data 31/05/2024
Profilo
Hong Ki Chae currently works at Da Information Co., Ltd., as Director from 2014 and Ettifos Co., as Director.
Mr. Chae also formerly worked at Dong-A Socio Holdings Co., Ltd., as Director, Senior Managing Director & Head-Finance, ST Pharm Co., Ltd., as Non-Executive Director, and DM Bio, Ltd.
(South Korea), as Director.
Mr. Chae received his graduate degree from Korea University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
NEXTIN INC.
0.18% | 30/09/2023 | 18 913 ( 0.18% ) | 898 830 $ | 31/05/2024 |
Posizioni attive di Hong Ki Chae
Società | Posizione | Inizio |
---|---|---|
Da Information Co., Ltd. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Hong Ki Chae
Società | Posizione | Fine |
---|---|---|
Ettifos Co.
![]() Ettifos Co. Miscellaneous Commercial ServicesCommercial Services Ettifos Co. is an American company that specializes in developing a compact and low-cost on-board unit (OBU) that enables users to receive vehicle-to-everything (V2X) services on their smartphones. The private company is based in an undisclosed location, and the CEO of the company is Yong Je Lim. The OBU is available in Dedicated Short-Range Communications (DSRC) or Cellular Vehicle-to-Everything (C-V2X) technology. | Direttore/Membro del Consiglio | - |
DM Bio, Ltd. (South Korea)
![]() DM Bio, Ltd. (South Korea) Pharmaceuticals: OtherHealth Technology DM Bio, Ltd. (KR) engages in the development and manufacture of pharmaceutical products. Its services include plant overview, cell culture, purification, fill and finish, and quality assurance. The company was founded in 2013 and is headquartered in Incheon, South Korea. | Direttore/Membro del Consiglio | - |
ST PHARM CO.,LTD. | Direttore/Membro del Consiglio | - |
DONG-A SOCIO HOLDINGS CO., LTD. | Direttore Finanziario/CFO | - |
Formazione di Hong Ki Chae
Korea University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
DONG-A SOCIO HOLDINGS CO., LTD. | Health Technology |
ST PHARM CO.,LTD. | Health Technology |
Aziende private | 3 |
---|---|
Da Information Co., Ltd. | |
DM Bio, Ltd. (South Korea)
![]() DM Bio, Ltd. (South Korea) Pharmaceuticals: OtherHealth Technology DM Bio, Ltd. (KR) engages in the development and manufacture of pharmaceutical products. Its services include plant overview, cell culture, purification, fill and finish, and quality assurance. The company was founded in 2013 and is headquartered in Incheon, South Korea. | Health Technology |
Ettifos Co.
![]() Ettifos Co. Miscellaneous Commercial ServicesCommercial Services Ettifos Co. is an American company that specializes in developing a compact and low-cost on-board unit (OBU) that enables users to receive vehicle-to-everything (V2X) services on their smartphones. The private company is based in an undisclosed location, and the CEO of the company is Yong Je Lim. The OBU is available in Dedicated Short-Range Communications (DSRC) or Cellular Vehicle-to-Everything (C-V2X) technology. | Commercial Services |
- Borsa valori
- Insiders
- Hong Ki Chae